As optimism rises regarding the Covid-19 vaccine, so does the specter of a return to in-person investor meetings. While we wait to learn how quickly we can each receive the vaccine, IR teams must now ask themselves whether they plan to return to in-person events in 2021. If so, what criteria need to be met and how does the vaccine’s rollout affect the type of in-person investor interactions that are prioritized?

Hear from a panel of investor relations and corporate access professionals about how they’re thinking about their event calendars for 2021.